25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

OSL (Oncosil) Stock Analysis
Buy, Hold or Sell?

Let's analyze Oncosil together

I guess you are interested in Oncosil Medical Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Oncosil’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Oncosil’s Price Targets

I'm going to help you getting a better view of Oncosil Medical Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.

1. Quick Overview

1.1. Quick analysis of Oncosil (30 sec.)










1.2. What can you expect buying and holding a share of Oncosil? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$-0.02
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
A$-0.02
Return On Investment
-2.0%

For what price can you sell your share?

Current Price per Share
A$1.21
Expected price per share
A$0.8 - A$1.2
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Oncosil (5 min.)




Live pricePrice per Share (EOD)
A$1.21
Intrinsic Value Per Share
A$-0.04 - A$-0.02
Total Value Per Share
A$-0.04 - A$-0.01

2.2. Growth of Oncosil (5 min.)




Is Oncosil growing?

Current yearPrevious yearGrowGrow %
How rich?$3m$6.4m-$3.3m-108.6%

How much money is Oncosil making?

Current yearPrevious yearGrowGrow %
Making money-$7.7m-$7.3m-$371.7k-4.8%
Net Profit Margin-2,306.1%-3,085.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Oncosil (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#241 / 292

Most Revenue
#252 / 292

Most Profit
#226 / 292

Most Efficient
#281 / 292
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Oncosil?

Welcome investor! Oncosil's management wants to use your money to grow the business. In return you get a share of Oncosil.

First you should know what it really means to hold a share of Oncosil. And how you can make/lose money.

Speculation

The Price per Share of Oncosil is A$1.205. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncosil.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncosil, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncosil.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-0.3%0.00-0.3%-0.01-0.5%-0.01-0.5%-0.01-0.4%-0.01-0.5%
Usd Book Value Change Per Share0.00-0.3%0.00-0.3%0.00-0.1%0.00-0.2%0.00-0.1%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.2%0.000.1%
Usd Total Gains Per Share0.00-0.3%0.00-0.3%0.00-0.1%0.00-0.2%0.000.1%0.000.0%
Usd Price Per Share0.00-0.00-0.01-0.01-0.03-0.05-
Price to Earnings Ratio-0.75--0.75--1.27--1.98--6.70--9.53-
Price-to-Total Gains Ratio-0.65--0.65--5.21--50.77--30.45--3.38-
Price to Book Ratio1.87-1.87-1.45-2.37-3.26-4.57-
Price-to-Total Gains Ratio-0.65--0.65--5.21--50.77--30.45--3.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.784455
Number of shares1274
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1274 shares)-5.081.52
Gains per Year (1274 shares)-20.336.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-20-3014-7-4
20-41-5027-152
30-61-7041-228
40-81-9054-3014
50-102-11068-3720
60-122-13081-4526
70-142-15095-5232
80-163-170108-6038
90-183-190122-6744
100-203-210135-7550

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%0.020.00.00.0%
Book Value Change Per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%8.012.00.040.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.09.010.0%1.00.019.05.0%
Total Gains per Share0.01.00.00.0%0.03.00.00.0%1.04.00.020.0%4.06.00.040.0%8.012.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Oncosil Medical Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.006-0.0060%-0.002-62%-0.003-53%-0.002-63%-0.001-80%
Book Value Per Share--0.0020.0020%0.008-74%0.007-69%0.012-82%0.016-87%
Current Ratio--3.2563.2560%7.160-55%5.875-45%7.019-54%9.628-66%
Debt To Asset Ratio--0.2950.2950%0.139+112%0.193+53%0.169+75%0.128+130%
Debt To Equity Ratio--0.4180.4180%0.161+159%0.250+67%0.212+98%0.155+170%
Dividend Per Share----0%-0%-0%0.004-100%0.002-100%
Enterprise Value--11396972.00011396972.0000%22152584.000-49%28395264.693-60%53004300.095-78%67834787.147-83%
Eps---0.005-0.0050%-0.009+77%-0.008+55%-0.008+49%-0.009+69%
Ev To Ebitda Ratio---0.960-0.9600%-1.984+107%-2.490+159%-8.290+763%-9.180+856%
Ev To Sales Ratio--22.06022.0600%60.250-63%101.694-78%132.056-83%76.960-71%
Free Cash Flow Per Share---0.005-0.0050%-0.010+91%-0.008+61%-0.008+52%-0.008+60%
Free Cash Flow To Equity Per Share---0.002-0.0020%-0.002-28%-0.002-29%0.001-417%0.006-138%
Gross Profit Margin--1.0161.0160%1.011+0%1.0210%1.038-2%1.397-27%
Intrinsic Value_10Y_max---0.016----------
Intrinsic Value_10Y_min---0.042----------
Intrinsic Value_1Y_max---0.006----------
Intrinsic Value_1Y_min---0.007----------
Intrinsic Value_3Y_max---0.015----------
Intrinsic Value_3Y_min---0.019----------
Intrinsic Value_5Y_max---0.020----------
Intrinsic Value_5Y_min---0.028----------
Market Cap17136064.000+48%8877568.0008877568.0000%14352480.000-38%21831037.027-59%43340718.495-80%58589839.447-85%
Net Profit Margin---23.061-23.0610%-30.850+34%-33.397+45%-30.140+31%-15.927-31%
Operating Margin---23.059-23.0590%-30.850+34%-34.559+50%-30.837+34%-16.674-28%
Operating Ratio--26.22826.2280%49.962-48%50.930-49%47.532-45%25.147+4%
Pb Ratio564.640+100%1.8741.8740%1.453+29%2.371-21%3.259-42%4.570-59%
Pe Ratio-224.473-30025%-0.745-0.7450%-1.265+70%-1.983+166%-6.698+799%-9.534+1180%
Price Per Share1.205+100%0.0040.0040%0.012-67%0.019-79%0.045-91%0.084-95%
Price To Free Cash Flow Ratio-242.652-30025%-0.805-0.8050%-1.262+57%-2.082+158%-6.739+737%-29.114+3514%
Price To Total Gains Ratio-196.674-30025%-0.653-0.6530%-5.208+698%-50.772+7677%-30.448+4564%-3.383+418%
Quick Ratio--2.9542.9540%6.880-57%5.593-47%6.835-57%10.311-71%
Return On Assets---1.773-1.7730%-0.989-44%-1.194-33%-0.899-49%-0.694-61%
Return On Equity---2.515-2.5150%-1.148-54%-1.541-39%-1.142-55%-0.841-67%
Total Gains Per Share---0.006-0.0060%-0.002-62%-0.003-53%0.002-434%0.001-852%
Usd Book Value--3083402.2593083402.2590%6432200.943-52%5594200.759-45%7730946.985-60%7819436.243-61%
Usd Book Value Change Per Share---0.004-0.0040%-0.001-62%-0.002-53%-0.001-63%-0.001-80%
Usd Book Value Per Share--0.0010.0010%0.005-74%0.005-69%0.008-82%0.010-87%
Usd Dividend Per Share----0%-0%-0%0.003-100%0.001-100%
Usd Enterprise Value--7419428.7727419428.7720%14421332.184-49%18485317.315-60%34505799.362-78%44160446.433-83%
Usd Eps---0.003-0.0030%-0.006+77%-0.005+55%-0.005+49%-0.006+69%
Usd Free Cash Flow---7174929.447-7174929.4470%-7404117.903+3%-7054856.620-2%-5970589.342-17%-4738676.849-34%
Usd Free Cash Flow Per Share---0.003-0.0030%-0.006+91%-0.005+61%-0.005+52%-0.005+60%
Usd Free Cash Flow To Equity Per Share---0.001-0.0010%-0.001-28%-0.001-29%0.000-417%0.004-138%
Usd Market Cap11155577.664+48%5779296.7685779296.7680%9343464.480-38%14212005.104-59%28214807.740-80%38141985.480-85%
Usd Price Per Share0.784+100%0.0030.0030%0.008-67%0.012-79%0.029-91%0.055-95%
Usd Profit---7756014.000-7756014.0000%-7384293.000-5%-7374528.000-5%-6338136.000-18%-5237360.100-32%
Usd Revenue--336327.432336327.4320%239357.727+41%242193.266+39%532930.474-37%1450113.437-77%
Usd Total Gains Per Share---0.004-0.0040%-0.001-62%-0.002-53%0.001-434%0.001-852%
 EOD+5 -3MRQTTM+0 -0YOY+13 -253Y+12 -265Y+11 -2910Y+8 -32

3.3 Fundamental Score

Let's check the fundamental score of Oncosil Medical Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-224.473
Price to Book Ratio (EOD)Between0-1564.640
Net Profit Margin (MRQ)Greater than0-23.061
Operating Margin (MRQ)Greater than0-23.059
Quick Ratio (MRQ)Greater than12.954
Current Ratio (MRQ)Greater than13.256
Debt to Asset Ratio (MRQ)Less than10.295
Debt to Equity Ratio (MRQ)Less than10.418
Return on Equity (MRQ)Greater than0.15-2.515
Return on Assets (MRQ)Greater than0.05-1.773
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.603
Ma 20Greater thanMa 501.079
Ma 50Greater thanMa 1001.239
Ma 100Greater thanMa 2001.624
OpenGreater thanClose1.195
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, develops and commercializes localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in Australia, New Zealand, and Europe. Its lead product is OncoSil, a single-use brachytherapy device for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.

Fundamental data was last updated by Penke on 2025-07-02 00:49:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Oncosil earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Net Profit Margin of -2,306.1%Β means thatΒ $-23.06 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncosil Medical Ltd:

  • The MRQ is -2,306.1%. The company is making a huge loss. -2
  • The TTM is -2,306.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-2,306.1%TTM-2,306.1%0.0%
TTM-2,306.1%YOY-3,085.0%+779.0%
TTM-2,306.1%5Y-3,014.0%+708.0%
5Y-3,014.0%10Y-1,592.7%-1,421.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,306.1%-8.0%-2,298.1%
TTM-2,306.1%-10.5%-2,295.6%
YOY-3,085.0%-13.3%-3,071.7%
3Y-3,339.7%-14.9%-3,324.8%
5Y-3,014.0%-11.0%-3,003.0%
10Y-1,592.7%-11.5%-1,581.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Oncosil is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • -177.3% Return on Assets means thatΒ Oncosil generatedΒ $-1.77 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncosil Medical Ltd:

  • The MRQ is -177.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -177.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-177.3%TTM-177.3%0.0%
TTM-177.3%YOY-98.9%-78.5%
TTM-177.3%5Y-89.9%-87.4%
5Y-89.9%10Y-69.4%-20.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-177.3%-2.2%-175.1%
TTM-177.3%-2.6%-174.7%
YOY-98.9%-3.5%-95.4%
3Y-119.4%-2.9%-116.5%
5Y-89.9%-2.7%-87.2%
10Y-69.4%-2.4%-67.0%
4.3.1.3. Return on Equity

Shows how efficient Oncosil is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • -251.5% Return on Equity means Oncosil generated $-2.52Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncosil Medical Ltd:

  • The MRQ is -251.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -251.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-251.5%TTM-251.5%0.0%
TTM-251.5%YOY-114.8%-136.7%
TTM-251.5%5Y-114.2%-137.3%
5Y-114.2%10Y-84.1%-30.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-251.5%-2.0%-249.5%
TTM-251.5%-3.2%-248.3%
YOY-114.8%-3.9%-110.9%
3Y-154.1%-4.0%-150.1%
5Y-114.2%-4.4%-109.8%
10Y-84.1%-6.3%-77.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Oncosil Medical Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Oncosil is operatingΒ .

  • Measures how much profit Oncosil makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • An Operating Margin of -2,305.9%Β means the company generated $-23.06 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncosil Medical Ltd:

  • The MRQ is -2,305.9%. The company is operating very inefficient. -2
  • The TTM is -2,305.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2,305.9%TTM-2,305.9%0.0%
TTM-2,305.9%YOY-3,085.0%+779.1%
TTM-2,305.9%5Y-3,083.7%+777.8%
5Y-3,083.7%10Y-1,667.4%-1,416.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2,305.9%-11.2%-2,294.7%
TTM-2,305.9%-13.7%-2,292.2%
YOY-3,085.0%-11.9%-3,073.1%
3Y-3,455.9%-11.5%-3,444.4%
5Y-3,083.7%-10.1%-3,073.6%
10Y-1,667.4%-10.8%-1,656.6%
4.3.2.2. Operating Ratio

Measures how efficient Oncosil is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Devices industry mean).
  • An Operation Ratio of 26.23 means that the operating costs are $26.23 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 26.228. The company is inefficient in keeping operating costs low. -1
  • The TTM is 26.228. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ26.228TTM26.2280.000
TTM26.228YOY49.962-23.735
TTM26.2285Y47.532-21.304
5Y47.53210Y25.147+22.385
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ26.2281.397+24.831
TTM26.2281.389+24.839
YOY49.9621.292+48.670
3Y50.9301.345+49.585
5Y47.5321.373+46.159
10Y25.1471.326+23.821
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Oncosil Medical Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Oncosil is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Devices industry mean).
  • A Current Ratio of 3.26Β means the company has $3.26 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 3.256. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.256. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.256TTM3.2560.000
TTM3.256YOY7.160-3.904
TTM3.2565Y7.019-3.762
5Y7.01910Y9.628-2.610
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2562.473+0.783
TTM3.2562.589+0.667
YOY7.1602.630+4.530
3Y5.8752.884+2.991
5Y7.0193.528+3.491
10Y9.6283.291+6.337
4.4.3.2. Quick Ratio

Measures if Oncosil is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Quick Ratio of 2.95Β means the company can pay off $2.95 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 2.954. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.954. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.954TTM2.9540.000
TTM2.954YOY6.880-3.926
TTM2.9545Y6.835-3.881
5Y6.83510Y10.311-3.476
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.9541.072+1.882
TTM2.9541.405+1.549
YOY6.8801.638+5.242
3Y5.5931.815+3.778
5Y6.8352.142+4.693
10Y10.3112.338+7.973
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Oncosil Medical Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of OncosilΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Oncosil to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.30Β means that Oncosil assets areΒ financed with 29.5% credit (debt) and the remaining percentage (100% - 29.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.295. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.295. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.295TTM0.2950.000
TTM0.295YOY0.139+0.156
TTM0.2955Y0.169+0.126
5Y0.16910Y0.128+0.040
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2950.409-0.114
TTM0.2950.419-0.124
YOY0.1390.401-0.262
3Y0.1930.391-0.198
5Y0.1690.424-0.255
10Y0.1280.457-0.329
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Oncosil is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A Debt to Equity ratio of 41.8% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncosil Medical Ltd:

  • The MRQ is 0.418. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.418. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.418TTM0.4180.000
TTM0.418YOY0.161+0.257
TTM0.4185Y0.212+0.207
5Y0.21210Y0.155+0.057
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4180.608-0.190
TTM0.4180.648-0.230
YOY0.1610.615-0.454
3Y0.2500.644-0.394
5Y0.2120.683-0.471
10Y0.1550.757-0.602
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Oncosil generates.

  • Above 15 is considered overpriced butΒ always compareΒ Oncosil to theΒ Medical Devices industry mean.
  • A PE ratio of -0.75 means the investor is paying $-0.75Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncosil Medical Ltd:

  • The EOD is -224.473. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.745. Based on the earnings, the company is expensive. -2
  • The TTM is -0.745. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-224.473MRQ-0.745-223.728
MRQ-0.745TTM-0.7450.000
TTM-0.745YOY-1.265+0.520
TTM-0.7455Y-6.698+5.953
5Y-6.69810Y-9.534+2.836
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-224.473-1.167-223.306
MRQ-0.745-1.518+0.773
TTM-0.745-1.257+0.512
YOY-1.265-2.406+1.141
3Y-1.983-1.572-0.411
5Y-6.698-1.927-4.771
10Y-9.534-1.706-7.828
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncosil Medical Ltd:

  • The EOD is -242.652. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.805. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.805. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-242.652MRQ-0.805-241.847
MRQ-0.805TTM-0.8050.000
TTM-0.805YOY-1.262+0.456
TTM-0.8055Y-6.739+5.933
5Y-6.73910Y-29.114+22.375
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-242.652-2.595-240.057
MRQ-0.805-3.183+2.378
TTM-0.805-1.612+0.807
YOY-1.262-3.344+2.082
3Y-2.082-2.453+0.371
5Y-6.739-3.239-3.500
10Y-29.114-3.398-25.716
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Oncosil is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Devices industry mean).
  • A PB ratio of 1.87 means the investor is paying $1.87Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncosil Medical Ltd:

  • The EOD is 564.640. Based on the equity, the company is expensive. -2
  • The MRQ is 1.874. Based on the equity, the company is underpriced. +1
  • The TTM is 1.874. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD564.640MRQ1.874+562.766
MRQ1.874TTM1.8740.000
TTM1.874YOY1.453+0.422
TTM1.8745Y3.259-1.385
5Y3.25910Y4.570-1.311
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD564.6402.011+562.629
MRQ1.8741.966-0.092
TTM1.8742.162-0.288
YOY1.4532.656-1.203
3Y2.3712.683-0.312
5Y3.2593.822-0.563
10Y4.5704.189+0.381
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncosil Medical Ltd.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Current Deferred Revenue -110-53-163-2-16519-1461460



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets6,718
Total Liabilities1,982
Total Stockholder Equity4,736
 As reported
Total Liabilities 1,982
Total Stockholder Equity+ 4,736
Total Assets = 6,718

Assets

Total Assets6,718
Total Current Assets6,329
Long-term Assets390
Total Current Assets
Cash And Cash Equivalents 4,501
Net Receivables 1,240
Inventory 122
Other Current Assets 466
Total Current Assets  (as reported)6,329
Total Current Assets  (calculated)6,329
+/-0
Long-term Assets
Property Plant Equipment 390
Long-term Assets  (as reported)390
Long-term Assets  (calculated)390
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,944
Long-term Liabilities38
Total Stockholder Equity4,736
Total Current Liabilities
Short-term Debt 32
Accounts payable 1,123
Other Current Liabilities 788
Total Current Liabilities  (as reported)1,944
Total Current Liabilities  (calculated)1,944
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt38
Long-term Liabilities  (as reported)38
Long-term Liabilities  (calculated)38
+/-0
Total Stockholder Equity
Common Stock90,094
Retained Earnings -92,781
Accumulated Other Comprehensive Income 7,424
Total Stockholder Equity (as reported)4,736
Total Stockholder Equity (calculated)4,736
+/-0
Other
Capital Stock90,094
Cash and Short Term Investments 4,501
Common Stock Shares Outstanding 2,219,392
Current Deferred Revenue0
Liabilities and Stockholders Equity 6,718
Net Debt -4,431
Net Invested Capital 4,736
Net Working Capital 4,385
Property Plant and Equipment Gross 525
Short Long Term Debt Total 71



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-30
> Total Assets 
947
8,185
7,002
6,167
5,228
2,959
3,030
2,524
6,244
9,636
7,407
15,897
11,805
19,882
11,668
24,060
14,150
13,069
11,474
6,718
6,71811,47413,06914,15024,06011,66819,88211,80515,8977,4079,6366,2442,5243,0302,9595,2286,1677,0028,185947
   > Total Current Assets 
918
3,447
2,538
2,296
1,988
1,919
3,030
2,521
3,592
9,617
7,352
15,805
11,689
19,796
11,606
23,921
13,620
12,745
11,235
6,329
6,32911,23512,74513,62023,92111,60619,79611,68915,8057,3529,6173,5922,5213,0301,9191,9882,2962,5383,447918
       Cash And Cash Equivalents 
887
2,821
1,901
1,746
1,395
1,552
2,727
2,412
3,511
2,739
2,523
9,780
8,001
15,205
7,689
20,998
12,240
11,280
9,394
4,501
4,5019,39411,28012,24020,9987,68915,2058,0019,7802,5232,7393,5112,4122,7271,5521,3951,7461,9012,821887
       Short-term Investments 
0
0
0
0
0
0
141
80
57
4,350
3,598
3,259
0
0
69
69
91
89
117
0
011789916969003,2593,5984,3505780141000000
       Net Receivables 
0
611
608
534
499
332
134
5
14
137
75
2,297
3,446
4,441
3,781
2,806
1,181
908
1,286
1,240
1,2401,2869081,1812,8063,7814,4413,4462,297751371451343324995346086110
       Other Current Assets 
31
14
29
15
95
35
27
25
10
2,391
1,157
469
243
150
136
118
198
557
555
466
4665555571981181361502434691,1572,391102527359515291431
   > Long-term Assets 
28
4,738
4,464
3,871
3,240
1,040
0
2
2,651
17
55
92
115
86
62
138
531
325
239
390
39023932553113862861159255172,651201,0403,2403,8714,4644,73828
       Property Plant Equipment 
3
1,078
804
520
254
140
0
2
4
17
55
92
115
86
62
138
531
325
239
390
39023932553113862861159255174201402545208041,0783
       Goodwill 
0
1,841
1,841
1,841
1,841
900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000009001,8411,8411,8411,8410
       Intangible Assets 
0
1,818
1,818
1,510
2,985
900
0
0
2,648
2,648
0
0
0
0
0
0
0
0
0
0
00000000002,6482,648009002,9851,5101,8181,8180
       Other Assets 
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
00000000003000000000
> Total Liabilities 
47
2,727
2,322
2,080
946
381
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,454
1,907
1,594
1,982
1,9821,5941,9072,4542,1599931,7281,6701,086446121193411173819462,0802,3222,72747
   > Total Current Liabilities 
47
1,367
1,391
1,495
471
347
117
41
193
121
446
1,086
1,670
1,728
993
2,159
2,133
1,768
1,569
1,944
1,9441,5691,7682,1332,1599931,7281,6701,086446121193411173474711,4951,3911,36747
       Short-term Debt 
0
214
180
149
296
0
141
80
57
4,350
3,598
3,259
0
0
110
110
163
165
146
32
32146165163110110003,2593,5984,350578014102961491802140
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
0
0
0
0
000027000000000000000
       Accounts payable 
41
512
645
744
471
83
105
7
54
36
171
217
901
857
364
1,356
1,227
931
960
1,123
1,1239609311,2271,356364857901217171365471058347174464551241
       Other Current Liabilities 
6
590
531
575
218
187
12
34
139
84
275
870
769
871
629
693
743
671
463
788
7884636717436936298717698702758413934121872185755315906
   > Long-term Liabilities 
0
1,361
931
585
475
34
0
0
0
0
0
0
0
0
364
321
321
139
25
38
382513932132136400000000344755859311,3610
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
321
139
25
0
0251393210000000000000000
       Other Liabilities 
0
412
188
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
000000000030000001884120
> Total Stockholder Equity
900
5,457
4,680
4,087
4,282
2,578
2,913
2,483
6,051
9,512
6,961
14,811
10,135
18,155
10,675
21,901
11,696
11,163
9,880
4,736
4,7369,88011,16311,69621,90110,67518,15510,13514,8116,9619,5126,0512,4832,9132,5784,2824,0874,6805,457900
   Common Stock
926
5,567
6,366
8,508
8,508
8,695
9,708
9,709
13,889
23,786
23,806
35,695
36,645
52,257
52,257
70,137
70,397
79,910
86,507
90,094
90,09486,50779,91070,39770,13752,25752,25736,64535,69523,80623,78613,8899,7099,7088,6958,5088,5086,3665,567926
   Retained Earnings -92,781-84,368-73,025-62,298-51,864-47,602-39,036-30,496-23,480-18,712-15,831-8,960-8,081-7,650-6,192-4,480-4,596-1,829-155-26
   Accumulated Other Comprehensive Income 
0
45
143
175
254
75
855
855
1,122
1,558
1,867
2,596
3,986
4,933
6,020
3,628
3,597
4,278
7,741
7,424
7,4247,7414,2783,5973,6286,0204,9333,9862,5961,8671,5581,12285585575254175143450
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
1,558
0
2,596
3,986
4,933
6,020
-18,273
-8,099
-6,885
0
0
00-6,885-8,099-18,2736,0204,9333,9862,59601,558000000000



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue517
Cost of Revenue-1,510
Gross Profit-993-993
 
Operating Income (+$)
Gross Profit-993
Operating Expense-12,040
Operating Income-11,984-13,033
 
Operating Expense (+$)
Research Development2,990
Selling General Administrative6,434
Selling And Marketing Expenses196
Operating Expense12,0409,620
 
Net Interest Income (+$)
Interest Income67
Interest Expense-4
Other Finance Cost-0
Net Interest Income63
 
Pretax Income (+$)
Operating Income-11,984
Net Interest Income63
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,914-12,055
EBIT - interestExpense = -11,917
-13,048
-11,910
Interest Expense4
Earnings Before Interest and Taxes (EBIT)-11,913-11,910
Earnings Before Interest and Taxes (EBITDA)-11,869
 
After tax Income (+$)
Income Before Tax-11,914
Tax Provision-0
Net Income From Continuing Ops-11,914-11,914
Net Income-11,914
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,550
Total Other Income/Expenses Net71-63
 

Technical Analysis of Oncosil
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncosil. The general trend of Oncosil is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncosil's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Oncosil Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncosil Medical Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.2 < 1.2 < 1.2.

The bearish price targets are: 1.2 > 0.9 > 0.8.

Know someone who trades $OSL? Share this with them.πŸ‘‡

Oncosil Medical Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncosil Medical Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncosil Medical Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncosil Medical Ltd. The current macd is 0.00515447.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Oncosil price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Oncosil. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Oncosil price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) ChartOncosil Medical Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncosil Medical Ltd. The current adx is 28.02.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Oncosil shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Oncosil Medical Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncosil Medical Ltd. The current sar is 0.93562359.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Oncosil Medical Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncosil Medical Ltd. The current rsi is 52.60. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Oncosil Medical Ltd Daily Relative Strength Index (RSI) ChartOncosil Medical Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncosil Medical Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncosil price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Oncosil Medical Ltd Daily Stochastic Oscillator ChartOncosil Medical Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncosil Medical Ltd. The current cci is 88.36.

Oncosil Medical Ltd Daily Commodity Channel Index (CCI) ChartOncosil Medical Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncosil Medical Ltd. The current cmo is 13.06.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Oncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) ChartOncosil Medical Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncosil Medical Ltd. The current willr is -22.72727273.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Oncosil is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Oncosil Medical Ltd Daily Williams %R ChartOncosil Medical Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Oncosil Medical Ltd.

Oncosil Medical Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncosil Medical Ltd. The current atr is 0.10755575.

Oncosil Medical Ltd Daily Average True Range (ATR) ChartOncosil Medical Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncosil Medical Ltd. The current obv is 59,115.

Oncosil Medical Ltd Daily On-Balance Volume (OBV) ChartOncosil Medical Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncosil Medical Ltd. The current mfi is 85.62.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Oncosil Medical Ltd Daily Money Flow Index (MFI) ChartOncosil Medical Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncosil Medical Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-02-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-23MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-28MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-16MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-06-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-23MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Oncosil Medical Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncosil Medical Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.603
Ma 20Greater thanMa 501.079
Ma 50Greater thanMa 1001.239
Ma 100Greater thanMa 2001.624
OpenGreater thanClose1.195
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Oncosil with someone you think should read this too:
  • Are you bullish or bearish on Oncosil? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncosil? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncosil Medical Ltd

I send you an email if I find something interesting about Oncosil Medical Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Oncosil Medical Ltd.

Receive notifications about Oncosil Medical Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.